GOSS - Gossamer Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 318.19%
52 Week High 326.50
52 Week Low 314.49
50-Day Moving Average 322.35
200-Day Moving Average 320.13

Share Statistics

Avg Vol (3 month) 3583.31k
Avg Vol (10 day) 3303.84k
Shares Outstanding 560.98M
Float 37.36M
% Held by Insiders 132.21%
% Held by Institutions 138.08%
Shares Short (Nov 15, 2019) 44.14M
Short Ratio (Nov 15, 2019) 48.13
Short % of Float (Nov 15, 2019) 49.70%
Short % of Shares Outstanding (Nov 15, 2019) 46.79%
Shares Short (prior month Oct 15, 2019) 44.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.72%
Return on Equity (ttm)-50.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -167.4M
Net Income Avi to Common (ttm)-164.4M
Diluted EPS (ttm)-3.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)446.47M
Total Cash Per Share (mrq)6.76
Total Debt (mrq)40M
Total Debt/Equity (mrq)10.03
Current Ratio (mrq)13.64
Book Value Per Share (mrq)6.54

Cash Flow Statement

Operating Cash Flow (ttm)-125.72M
Levered Free Cash Flow (ttm)-72.26M